Literature DB >> 13180501

Studies on Vi antigen. VI. Immunization of human beings with purified Vi antigen.

M LANDY.   

Abstract

Entities:  

Keywords:  ANTIGENS AND ANTIBODIES

Mesh：

Substances：

Year:  1954        PMID： 13180501     DOI： 10.1093/oxfordjournals.aje.a119703

Source DB:  PubMed          Journal:  Am J Hyg        ISSN： 0096-5294


× No keyword cloud information.
  18 in total

1.  Protection of mice by living Vi and O vaccines against death caused by Salmonella paratyphi C.

Authors:  G T ARCHER; J L WHITBY
Journal:  J Hyg (Lond)       Date:  1957-12

2.  Antibody responses of man to three types of antityphoid immunizing agents: heat-phenol fluid vaccine, acetone-dehydrated vaccine, and isolated Vi and O antigens.

Authors:  M LANDY; S GAINES; J R SEAL; J E WHITSIDE
Journal:  Am J Public Health Nations Health       Date:  1954-12

Review 3.  The development of vaccines: how the past led to the future.

Authors:  Stanley A Plotkin; Susan L Plotkin
Journal:  Nat Rev Microbiol       Date:  2011-10-03       Impact factor: 60.633

4.  The human primary immune response to keyhole limpet haemocyanin: interrelationships of delayed hypersensitivity, antibody response and in vitro blast transformation.

Authors:  J E Curtis; E M Hersh; J E Harris; C McBride; E J Freireich
Journal:  Clin Exp Immunol       Date:  1970-04       Impact factor: 4.330

5.  Engineering, conjugation, and immunogenicity assessment of Escherichia coli O121 O antigen for its potential use as a typhoid vaccine component.

Authors:  Michael Wetter; Michael Kowarik; Michael Steffen; Paula Carranza; Giampietro Corradin; Michael Wacker
Journal:  Glycoconj J       Date:  2012-10-06       Impact factor: 2.916

6.  Factors Affecting Formation of Incomplete Vi Antibody in Mice.

Authors:  S Gaines; J A Currie; J G Tully
Journal:  J Bacteriol       Date:  1965-09       Impact factor: 3.490

7.  Synthesis and immunological properties of Vi and di-O-acetyl pectin protein conjugates with adipic acid dihydrazide as the linker.

Authors:  Z Kossaczka; S Bystricky; D A Bryla; J Shiloach; J B Robbins; S C Szu
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

8.  Vi antigen from Salmonella typhosa and immunity against typhoid fever. 11. Safety and antigenicity in humans.

Authors:  D M Levin; K H Wong; H Y Reynolds; A Sutton; R S Northrup
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

9.  Vi capsular polysaccharide-protein conjugates for prevention of typhoid fever. Preparation, characterization, and immunogenicity in laboratory animals.

Authors:  S C Szu; A L Stone; J D Robbins; R Schneerson; J B Robbins
Journal:  J Exp Med       Date:  1987-11-01       Impact factor: 14.307

10.  Laboratory and preliminary clinical characterization of Vi capsular polysaccharide-protein conjugate vaccines.

Authors:  S C Szu; D N Taylor; A C Trofa; J D Clements; J Shiloach; J C Sadoff; D A Bryla; J B Robbins
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.